Literature DB >> 3116950

Production of interferon and lymphoproliferative response in whole blood cultures derived from patients with atopic dermatitis.

A Kapp1, R Gillitzer, H Kirchner, E Schöpf.   

Abstract

Enhanced susceptibility to viral infections has been reported repeatedly in atopic dermatitis (AD). A difference in the capacity to produce interferons (IFN) in response to viral antigens may be the cause. In the present study we investigated the in vitro IFN production of leukocytes from AD patients in response to different stimuli. Furthermore, the lymphoproliferative responses were tested. The patients showed moderate to severe disease activity. Whole blood cultures of 25 AD patients and 21 healthy nonatopic controls were stimulated with the mitogens phytohemagglutinin (PHA), concanavalin A (ConA), and pokeweed mitogen (PWM), with tuberculin derivative (PPD) and tetanus antigen as IFN-gamma inducers, and with C. parvum, poly I-poly C, and herpes simplex virus (HSV) as inducers of IFN-a. Lymphoproliferation was assayed in 5-day cultures in parallel. In AD no significant difference of the IFN production was found in comparison with the controls with any stimuli tested. The lymphoproliferative response of leukocytes of patients with AD was significantly decreased upon stimulation with PHA, Con A, PWM, and PPD. We suggest that in AD the described susceptibility to viral infections is not due to an altered capability of leukocytes to generate IFN.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3116950     DOI: 10.1007/bf00585921

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  17 in total

1.  ECZEMA VACCINATUM.

Authors:  P W COPEMAN; H J WALLACE
Journal:  Br Med J       Date:  1964-10-10

Review 2.  The interferon system as an integral part of the defense system against infections.

Authors:  H Kirchner
Journal:  Antiviral Res       Date:  1986-01       Impact factor: 5.970

3.  A whole-blood lymphoproliferation assay for measuring cellular immunity against herpes viruses.

Authors:  M Leroux; L Schindler; R Braun; H W Doerr; H P Geisen; H Kirchner
Journal:  J Immunol Methods       Date:  1985-05-23       Impact factor: 2.303

Review 4.  Immunoregulatory abnormalities in atopic dermatitis.

Authors:  D Y Leung; R S Geha
Journal:  Clin Rev Allergy       Date:  1986-02

Review 5.  Interferons, a group of multiple lymphokines.

Authors:  H Kirchner
Journal:  Springer Semin Immunopathol       Date:  1984

6.  Eruptive molluscum contagiosum in atopic dermatitis.

Authors:  L M Solomon; P Telner
Journal:  Can Med Assoc J       Date:  1966-11-05       Impact factor: 8.262

7.  Modulation of natural killer cell activity in patients with atopic dermatitis.

Authors:  J R Jensen; T T Sand; A S Jørgensen; K Thestrup-Pedersen
Journal:  J Invest Dermatol       Date:  1984-01       Impact factor: 8.551

8.  Natural killer cell activity in atopic dermatitis: a sequential study.

Authors:  R S Lever; M J Lesko; R M MacKie; D M Parrott
Journal:  Clin Allergy       Date:  1985-09

9.  A whole-blood technique for testing production of human interferon by leukocytes.

Authors:  H Kirchner; C Kleinicke; W Digel
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

Review 10.  [Pathogenesis of atopic dermatitis].

Authors:  E Schöpf; A Kapp
Journal:  Immun Infekt       Date:  1985-09
View more
  3 in total

1.  In vivo and in vitro effects of glucocorticoids on lectin-induced blastogenesis in atopic dermatitis.

Authors:  M Rupprecht; R Rupprecht; N Wodarz; H U Braner; J Kornhuber; H U Koch; P Riederer; O P Hornstein
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

2.  Allergen presentation by epidermal Langerhans' cells from patients with atopic dermatitis is mediated by IgE.

Authors:  G C Mudde; F C Van Reijsen; G J Boland; G C de Gast; P L Bruijnzeel; C A Bruijnzeel-Koomen
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

3.  In vitro interleukin 4 and interferon-gamma production by mononuclear cells from atopic dermatitis patients.

Authors:  S Well; F Diel
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.